Study of Immunogenicity of Anti-HAV Immunisation in HIV-1 Infected Patients, Co-infected or Not With HBV and/or HCV. HEP.A.VAC Study.
Phase of Trial: Phase III
Latest Information Update: 15 Dec 2011
At a glance
- Drugs Hepatitis A vaccine inactivated (Primary)
- Indications Hepatitis A
- Focus Pharmacodynamics
- Acronyms HEPAVAC
- 31 Aug 2018 Biomarkers information updated
- 28 Jun 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 28 Jun 2011 Actual end date (Oct 2009) added as reported by ClinicalTrials.gov.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History